Malaria treatment failures after artemisinin-based therapy in three expatriates: could improved manufacturer information help to decrease the risk of treatment failure?
about
A cross-sectional investigation of the quality of selected medicines in Cambodia in 2010Peroxisome proliferator activating receptor (PPAR) in cerebral malaria (CM): a novel target for an additional therapy.Health risks and risk-taking behaviors among International Committee of the Red Cross (ICRC) expatriates returning from humanitarian missions.Artemisinin-Naphthoquine Combination (ARCO®): An Overview of the Progress.
P2860
Malaria treatment failures after artemisinin-based therapy in three expatriates: could improved manufacturer information help to decrease the risk of treatment failure?
description
2006 nî lūn-bûn
@nan
2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Malaria treatment failures aft ...... the risk of treatment failure?
@ast
Malaria treatment failures aft ...... the risk of treatment failure?
@en
type
label
Malaria treatment failures aft ...... the risk of treatment failure?
@ast
Malaria treatment failures aft ...... the risk of treatment failure?
@en
prefLabel
Malaria treatment failures aft ...... the risk of treatment failure?
@ast
Malaria treatment failures aft ...... the risk of treatment failure?
@en
P2093
P2860
P356
P1433
P1476
Malaria treatment failures aft ...... the risk of treatment failure?
@en
P2093
Louis Loutan
Walter Taylor
Yves Jackson
P2860
P2888
P356
10.1186/1475-2875-5-81
P577
2006-10-04T00:00:00Z
P5875
P6179
1048543507